Lord, Abbett & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-64,081
| Closed | -$67.4M | – | 569 |
|
|
2024
Q3 | $67.4M | Sell |
64,081
-22,151
| -26% | -$23.3M | 0.21% | 139 |
|
|
2024
Q2 | $90.6M | Buy |
86,232
+39,950
| +86% | +$42M | 0.3% | 93 |
|
|
2024
Q1 | $44.5M | Buy |
+46,282
| New | +$44.5M | 0.14% | 197 |
|
|
2020
Q3 | – | Sell |
-78,377
| Closed | -$48.9M | – | 674 |
|
|
2020
Q2 | $48.9M | Buy |
78,377
+32,960
| +73% | +$20.6M | 0.17% | 188 |
|
|
2020
Q1 | $22.2M | Buy |
+45,417
| New | +$22.2M | 0.1% | 309 |
|
|
2019
Q2 | – | Sell |
-36,117
| Closed | -$14.8M | – | 818 |
|
|
2019
Q1 | $14.8M | Buy |
+36,117
| New | +$14.8M | 0.05% | 478 |
|
|
2017
Q4 | – | Sell |
-44,268
| Closed | -$19.8M | – | 899 |
|
|
2017
Q3 | $19.8M | Sell |
44,268
-61,468
| -58% | -$27.5M | 0.06% | 477 |
|
|
2017
Q2 | $51.9M | Buy |
+105,736
| New | +$51.9M | 0.15% | 205 |
|
|
2016
Q4 | – | Sell |
-14,497
| Closed | -$5.83M | – | 943 |
|
|
2016
Q3 | $5.83M | Sell |
14,497
-13,212
| -48% | -$5.31M | 0.02% | 703 |
|
|
2016
Q2 | $9.68M | Buy |
27,709
+13,360
| +93% | +$4.67M | 0.03% | 590 |
|
|
2016
Q1 | $5.17M | Sell |
14,349
-54,981
| -79% | -$19.8M | 0.02% | 695 |
|
|
2015
Q4 | $37.6M | Sell |
69,330
-5,168
| -7% | -$2.81M | 0.11% | 279 |
|
|
2015
Q3 | $34.7M | Sell |
74,498
-15,430
| -17% | -$7.18M | 0.1% | 297 |
|
|
2015
Q2 | $45.9M | Sell |
89,928
-2,140
| -2% | -$1.09M | 0.12% | 274 |
|
|
2015
Q1 | $41.6M | Buy |
92,068
+20,617
| +29% | +$9.31M | 0.11% | 300 |
|
|
2014
Q4 | $29.3M | Buy |
71,451
+27,068
| +61% | +$11.1M | 0.07% | 376 |
|
|
2014
Q3 | $16M | Buy |
+44,383
| New | +$16M | 0.04% | 532 |
|
|
2013
Q4 | – | Sell |
-10,965
| Closed | -$3.43M | – | 1083 |
|
|
2013
Q3 | $3.43M | Buy |
+10,965
| New | +$3.43M | 0.01% | 885 |
|